Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

IN BRIEF: PureTech Health's Gelesis wins USD15 million Plenity order

21st Jun 2022 14:24

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics - Investee Gelesis Holdings Inc receives another USD15 million pre-order for its weight management aid product Plenity from its distribution partner, New-York based telehealth firm Ro. It brings the total orders from Ro to USD55 million, out of which USD45 million was ordered in the last 12 months, PureTech Health adds.

Current stock price: 166.60 pence, up 1.2% on Tuesday

12-month change: down 51%

By Tom Budszus; [email protected]

Copyright 2022 Alliance News Limited. All Rights Reserved.


Related Shares:

PureTech
FTSE 100 Latest
Value8,809.74
Change53.53